Phosphorylated Tyrosine-containing Proteins in Primary Lung Cancer Correlates with Proliferation and Prognosis

Overview

Journal Br J Cancer

Specialty Oncology

Date 2002 Jun 27

PMID 12085182

Authors

Y Gong

T Hirano

Y Kato

K Yoshida

Y Shou

T Ohira

N Ikeda

Y Ebihara

H Kato

Affiliations

Soon will be listed here.

Abstract

To determine the usefulness of tyrosine phosphorylation in evaluating biological characteristics, we attempted to evaluate the relationship between the amount of phosphorylated tyrosine-containing proteins and clinicopathological factors, cell proliferation and outcome in non-small cell lung cancer. To evaluate phosphorylated tyrosine-containing proteins we used 96 surgically resected materials of non-small cell lung cancer and normal peripheral lung, while immunohistochemical evaluation was performed. Cell proliferating ability was evaluated using the labelling index of proliferating cell nuclear antigen-positive nuclear staining cells. There were statistically significant differences between the expression levels of phosphorylated tyrosine-containing proteins of normal and cancerous tissues (P<0.0001). Evaluations based on clinicopathological factors apart from histopathological differentiation, showed no statistically significant differences of phosphorylated tyrosine-containing proteins expression. However, phosphorylated tyrosine-containing proteins correlated with cell proliferation activity evaluated (P((Low, High))<0.0001; P((Low, Int)) <0.0001; P((Int, High))<0.0001). Furthermore, non-small cell lung cancer cases with high expression and intermediate expression of phosphorylated tyrosine-containing proteins had a significantly shorter disease-free postoperative survival than those with low expression of phosphorylated tyrosine-containing proteins using log-rank analysis (P((Low, Int)) <0.0028; P((Low, High))=0.0002). Furthermore, phosphorylated tyrosine-containing proteins expression level statistically contributed to disease-free survival in Cox's proportional hazard model. Therefore, phosphorylated tyrosine-containing proteins in non-small cell lung cancer tissues seem to reflect its biological malignancy, and this evaluation may be valuable for constructing the most appropriate therapeutic strategy.

References

Hamaguchi M, Matsuyoshi N, Ohnishi Y, Gotoh B, Takeichi M, Nagai Y . p60v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system. EMBO J. 1993; 12(1):307-14. PMC: 413207. DOI: 10.1002/j.1460-2075.1993.tb05658.x. View

Kokai Y, Dobashi K, Weiner D, Myers J, Nowell P, Greene M . Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products. Proc Natl Acad Sci U S A. 1988; 85(15):5389-93. PMC: 281762. DOI: 10.1073/pnas.85.15.5389. View

Sato Y, Mukai K, Watanabe S, Goto M, Shimosato Y . The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am J Pathol. 1986; 125(3):431-5. PMC: 1888473. View

Cohen B, Yoakim M, Piwnica-Worms H, Roberts T, Schaffhausen B . Tyrosine phosphorylation is a signal for the trafficking of pp85, an 85-kDa phosphorylated polypeptide associated with phosphatidylinositol kinase activity. Proc Natl Acad Sci U S A. 1990; 87(12):4458-62. PMC: 54134. DOI: 10.1073/pnas.87.12.4458. View

Druker B, Mamon H, Roberts T . Oncogenes, growth factors, and signal transduction. N Engl J Med. 1989; 321(20):1383-91. DOI: 10.1056/NEJM198911163212007. View

Fearon E, Vogelstein B . A genetic model for colorectal tumorigenesis. Cell. 1990; 61(5):759-67. DOI: 10.1016/0092-8674(90)90186-i. View

Vogt M, Haggblom C, Swift S . Growth factor independence and indefinite growth ("immortalization") appear simultaneously after crisis in murine myelocytes expressing v-myc. Oncogene Res. 1989; 4(1):19-28. View

Hamaguchi M, Grandori C, Hanafusa H . Phosphorylation of cellular proteins in Rous sarcoma virus-infected cells: analysis by use of anti-phosphotyrosine antibodies. Mol Cell Biol. 1988; 8(8):3035-42. PMC: 363529. DOI: 10.1128/mcb.8.8.3035-3042.1988. View

Shimoyama Y, Nagafuchi A, Fujita S, Gotoh M, Takeichi M, Tsukita S . Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness. Cancer Res. 1992; 52(20):5770-4. View

10.

Ohsaki Y, Toyoshima E, Fujiuchi S, Matsui H, Hirata S, Miyokawa N . bcl-2 and p53 protein expression in non-small cell lung cancers: correlation with survival time. Clin Cancer Res. 1996; 2(5):915-20. View

11.

Goodman P, Wood C, Vassilev A, Mao C, Uckun F . Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia. Oncogene. 2001; 20(30):3969-78. DOI: 10.1038/sj.onc.1204515. View

12.

Takeshima E, Hamaguchi M, Watanabe T, Akiyama S, Kataoka M, Ohnishi Y . Aberrant elevation of tyrosine-specific phosphorylation in human gastric cancer cells. Jpn J Cancer Res. 1991; 82(12):1428-35. PMC: 5918361. DOI: 10.1111/j.1349-7006.1991.tb01816.x. View

13.

Reynolds A, Roesel D, Kanner S, Parsons J . Transformation-specific tyrosine phosphorylation of a novel cellular protein in chicken cells expressing oncogenic variants of the avian cellular src gene. Mol Cell Biol. 1989; 9(2):629-38. PMC: 362640. DOI: 10.1128/mcb.9.2.629-638.1989. View

14.

Kiyokawa E, Takai S, Tanaka M, Iwase T, Suzuki M, Xiang Y . Overexpression of ERK, an EPH family receptor protein tyrosine kinase, in various human tumors. Cancer Res. 1994; 54(14):3645-50. View

15.

Matsuyoshi N, Hamaguchi M, Taniguchi S, Nagafuchi A, Tsukita S, Takeichi M . Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts. J Cell Biol. 1992; 118(3):703-14. PMC: 2289552. DOI: 10.1083/jcb.118.3.703. View

16.

Sozzi G, Miozzo M, Donghi R, Pilotti S, Cariani C, Pastorino U . Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res. 1992; 52(21):6079-82. View

17.

Imaizumi M, Nishimura M, Takeuchi S, Murase M, Hamaguchi M . Role of tyrosine specific phosphorylation of cellular proteins, especially EGF receptor and p125FAK in human lung cancer cells. Lung Cancer. 1997; 17(1):69-84. DOI: 10.1016/s0169-5002(97)00650-8. View

18.

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

19.

Dazzi H, Hasleton P, Thatcher N, Barnes D, Wilkes S, Swindell R . Expression of epidermal growth factor receptor (EGF-R) in non-small cell lung cancer. Use of archival tissue and correlation of EGF-R with histology, tumour size, node status and survival. Br J Cancer. 1989; 59(5):746-9. PMC: 2247242. DOI: 10.1038/bjc.1989.156. View

20.

Hunter T, Sefton B . Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc Natl Acad Sci U S A. 1980; 77(3):1311-5. PMC: 348484. DOI: 10.1073/pnas.77.3.1311. View